# Piotr Kuna

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/piotr-kuna/

## Facts

| Field | Value |
| --- | --- |
| Citations | 26,489 |
| Field | Asthma and respiratory diseases |
| h-index | 73 |
| i10-index | 299 |
| Last Known Institution | Medical University of Lodz |
| OpenAlex ID | https://openalex.org/A5001308400 |
| ORCID iD | https://orcid.org/0000-0003-2401-0070 |
| Works | 803 |

## Researcher papers

- [Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*](https://scholariq.org/papers/allergic-rhinitis-and-its-impact-on-asthma-aria-2008/)
- [Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision](https://scholariq.org/papers/allergic-rhinitis-and-its-impact-on-asthma-aria-guidelines-2016-revision/)
- [Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs](https://scholariq.org/papers/allergic-rhinitis-and-its-impact-on-asthma-aria-achievements-in-10-years-and/)
- [Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence](https://scholariq.org/papers/next-generation-allergic-rhinitis-and-its-impact-on-asthma-aria-guidelines-for/)
- [International consensus on (ICON) pediatric asthma](https://scholariq.org/papers/international-consensus-on-icon-pediatric-asthma/)
- [Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma](https://scholariq.org/papers/efficacy-of-a-house-dust-mite-sublingual-allergen-immunotherapy-tablet-in-adults/)
- [Sub-Lingual Immunotherapy](https://scholariq.org/papers/sub-lingual-immunotherapy/)
- [2019 ARIA Care pathways for allergen immunotherapy](https://scholariq.org/papers/2019-aria-care-pathways-for-allergen-immunotherapy/)
- [Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study](https://scholariq.org/papers/long-term-safety-and-efficacy-of-tezepelumab-in-people-with-severe-uncontrolled/)

## Researcher topics

- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)
- [Respiratory and Cough-Related Research](https://scholariq.org/topics/respiratory-and-cough-related-research/)
- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)
- [Inhalation and Respiratory Drug Delivery](https://scholariq.org/topics/inhalation-and-respiratory-drug-delivery/)

## Researcher university

- [Medical University of Lodz](https://scholariq.org/institutions/medical-university-of-lodz/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.